Microbial products—ranging from biostimulants to biopesticides—are at the center of regulatory evolution in agricultural inputs. As more developers bring living or fermentation-derived organisms to market, agencies worldwide are reevaluating how these inputs are defined, registered, and controlled.
In the United States, the EPA has reaffirmed its oversight of microbial pesticides, but recent guidance distinguishes between live microbial products with pesticidal claims and non-plant-protectant biologicals, which may fall outside EPA scope. Meanwhile, USDA and FDA are being increasingly pulled into discussions when products blur lines between plant, animal, and food applications.
Europe continues to apply strict risk assessment protocols under Regulation (EC) No. 1107/2009, often treating microbial products similarly to synthetic chemicals. However, industry groups are pushing for a more proportionate framework under the evolving Biologicals Regulation Initiative.
India, Brazil, and Argentina are actively revising their frameworks to reflect the growing use of native soil microbes and fermentation-derived metabolites, with new registration tracks proposed for non-synthetic biostimulants. These updates are critical, as many AgTech innovators now rely on microbial platforms for scalability and sustainability.
Why It Matters
For companies developing microbial consortia, protein-based signals, or fermentation byproducts, the distinction between “biostimulant,” “biopesticide,” or “fertilizer” is more than semantics. It determines the required studies, regulatory timelines, and global trade implications.
At Hjelle, we work with clients to:
- Align microbial claims with the correct regulatory path
- Prepare data to meet divergent jurisdictional standards
- Anticipate reclassification risks in key markets
- Engage early with agencies to avoid missteps
With global regulatory momentum building around microbial innovation, clear strategy is no longer optional—it’s foundational.
Want to know how your product may be classified in key markets?
Get in touch to explore tailored risk scenarios.
